15 / 21
Page 45
December 06-07 , 2018
Amsterdam, Nether l ands
Journal of Neuropsychiatry
ISSN: 2471-8548
Alzheimer’s and Dementia 2018
1 3
t h
W o r l d c o n g r e s s o n
Alzheimer’s and Dementia
I
maging can have positive impact in identifying patients with AD before the onset of the symptoms. There are studies suggesting
that machine learning techniques such as support vector machine (SVM) and fMRI can be used successfully in identifying
patients 5 to 10 years before the onset of AD. However, there are some important items that has to be addressed: validation
of machine learning and fMRI as in vitro diagnostic methods, access to that information (insurance companies, healthcare
providers), high cost.
stanevanatasha@gmail.comOpportunities, challenges and ethics in amyloid and
neuroimaging
Natasha Staneva
Sr CRA in a global contract research Organisation, Scotland
J Neurol Neurosci 2018, Volume: 2
DOI: 10.21767/2471-8548-C1-003